Lepu Biopharma Co., Ltd. (HKG: 2157)
Hong Kong
· Delayed Price · Currency is HKD 3.270
-0.280 (-7.89%)
Nov 13, 2024, 11:16 AM HKT
Lepu Biopharma Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -72.62 | -22.1 | -689.05 | -1,011 | -581.85 | -447.04 |
| Depreciation & Amortization | 99.88 | 102.43 | 95.45 | 95.25 | 84.11 | 49.27 |
| Other Amortization | 0.15 | 0.15 | - | - | - | - |
| Loss (Gain) From Sale of Assets | - | - | -0.61 | - | - | -0.07 |
| Loss (Gain) From Sale of Investments | -220.26 | -220.26 | - | -5.37 | -5.54 | -1.66 |
| Loss (Gain) on Equity Investments | 27.34 | 27.34 | 32.23 | 17.7 | 12.08 | 8.68 |
| Stock-Based Compensation | 18.57 | 18.57 | 30.42 | 113.51 | 5.22 | 143.7 |
| Provision & Write-off of Bad Debts | 0.21 | 0.21 | - | - | - | - |
| Other Operating Activities | -155.33 | -168.87 | 21.97 | 58.61 | 132.18 | 22.18 |
| Change in Accounts Receivable | -38.01 | -38.01 | - | -20.37 | -76.15 | -46.36 |
| Change in Inventory | -5.35 | -5.35 | 0.12 | -4.62 | -11.49 | -8.08 |
| Change in Accounts Payable | 50.03 | 50.03 | 2.55 | 134.56 | 18.73 | 33.4 |
| Change in Unearned Revenue | - | - | - | - | - | 12 |
| Change in Other Net Operating Assets | 5.03 | 5.03 | 25.99 | - | - | - |
| Operating Cash Flow | -290.37 | -250.84 | -480.93 | -621.74 | -422.69 | -233.99 |
| Capital Expenditures | -22.34 | -28 | -110.45 | -213.39 | -239.26 | -318.47 |
| Sale of Property, Plant & Equipment | - | - | - | - | 0.77 | - |
| Cash Acquisitions | -0.68 | -65.68 | -10 | -100 | -69.57 | -50 |
| Sale (Purchase) of Intangibles | -20.57 | -13.2 | -5 | -6.12 | -71.7 | -45.36 |
| Investment in Securities | 125.14 | 125.14 | 50.79 | 315.61 | -369.91 | -7.97 |
| Other Investing Activities | - | - | - | - | - | 6.48 |
| Investing Cash Flow | 81.55 | 18.26 | -74.66 | -3.89 | -749.67 | -415.32 |
| Short-Term Debt Issued | - | - | - | - | 50 | 360 |
| Long-Term Debt Issued | - | 403.55 | 437.46 | 146.11 | 59 | 118.27 |
| Total Debt Issued | 465.75 | 403.55 | 437.46 | 146.11 | 109 | 478.27 |
| Short-Term Debt Repaid | - | - | - | - | -50 | - |
| Long-Term Debt Repaid | - | -383.99 | -88.76 | -15.82 | -54.13 | -35.9 |
| Total Debt Repaid | -505.67 | -383.99 | -88.76 | -15.82 | -104.13 | -35.9 |
| Net Debt Issued (Repaid) | -39.93 | 19.56 | 348.7 | 130.3 | 4.87 | 442.37 |
| Issuance of Common Stock | 213.38 | - | 739.23 | 261.12 | 1,381 | 322.2 |
| Other Financing Activities | -32.54 | -30.58 | -55.96 | -11.11 | 0.81 | 5.82 |
| Financing Cash Flow | 140.91 | -11.01 | 1,032 | 380.31 | 1,387 | 770.39 |
| Foreign Exchange Rate Adjustments | 0.08 | 0.21 | 37.86 | -2.38 | 0 | 0 |
| Net Cash Flow | -67.82 | -243.38 | 514.23 | -247.7 | 214.32 | 121.08 |
| Free Cash Flow | -312.71 | -278.84 | -591.38 | -835.12 | -661.95 | -552.47 |
| Free Cash Flow Margin | -152.48% | -123.73% | -3797.71% | - | - | - |
| Free Cash Flow Per Share | -0.19 | -0.17 | -0.36 | -0.55 | -0.58 | -0.85 |
| Cash Interest Paid | 27.9 | 29.38 | 21.39 | 9.29 | 12.7 | 0.69 |
| Levered Free Cash Flow | -150.46 | -227.17 | -449.59 | -514.38 | -653.55 | - |
| Unlevered Free Cash Flow | -140.94 | -217.99 | -444.93 | -512.69 | -600.3 | - |
| Change in Net Working Capital | -58.96 | 53.83 | 53.81 | -87.86 | 99.01 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.